samedan logo
 
 
spacer
home > directory > Simons Security Systems GmbH
PHARMACEUTICAL INDUSTRY DIRECTORY

Simons Security Systems GmbH

Simons Security Systems GmbH

Guaranteed protection against product piracy with SECUTAG®, the smallest micro colour-code particles worldwide

3S Simons Security Systems GmbH, located in the German Nottuln, is a renowned manufacturer of micro colour-code systems ensuring product security and anti-counterfeit action. SECUTAG, the smallest micro colour-code particles worldwide, serve as unambiguous identification marks of genuine products and have been forgery-proof for more than a decade. Besides research and development of innovative security technologies, the product portfolio of the company also includes a vast array of services in the realm of individually designed product security. The negative economic impact of product piracy has challenged 3S Simons Security Systems GmbH to develop continuously optimised security strategies providing cross-sectoral protection against counterfeiters.

3S Simons Security Systems GmbH is a spin-off of Simons Druck und Vertrieb GmbH and was established as an independent company in 2007. The management under director Dirk Simons decided on this move to advance sustainable expansion of both business areas, Security Technologies and Security Services. Simons Druck und Vertrieb GmbH will continue business following their core competences in the fields of label printing and labelling. The company was founded by Rolf Simons in 1983. The specialisation on printed security products provided the ideal setting for the development of SECUTAG. As for the anti-counterfeit system, both partners combine their technical and strategic know-how in security matters, a vast range of services, and decades of experience in the production of security tags and sealing label. 3S Simons Security Systems GmbH is now extending its product range to include a new system solution that combines the logistic benefits of traceability code labelling with the counterfeit-proof micro colour-code system SECUTAG.

Following the slogan „your code for safety“, SECUTAG marks the genuine products with colour-code particles, which enable unambiguous distinction between branded goods and counterfeits. Industrial production of the micro colour-code particles requires up to 40 production steps and special technical products. The process is protected by patents all over the globe and has proven to be forgery-proof for above ten years. The colour codes are accepted as decisive evidence by international courts, serving global defence of industrial property rights and supporting the fight against unjustified damage and product liability claims. In this respect, the product security system acts as deterrent against counterfeiters, while simultaneously protecting and promoting the image of brand-owners as guarantors of high-quality goods. This in turn can be transformed into a sales argument by the company. Every manufacturer gets his individual company code. The system’s flexible application renders it suitable for a broad range of products. Integration into any kind of production line is easily accomplished without costly modifications in the manufacturing process.

SECUTAG is used by companies active in the most diverse industries worldwide. The anti-counterfeit system has proven its reliability, evidence is furnished by the numerous prizes that have been awarded in recent years, for example by the “World Packaging Organization”, the “Salon International des Inventions” or the “Interpack” trade fair.

For further information on the SECUTAG® security system, please visit www.3SGmbH.com

+49 (0) 2502 2333 0
nicole.golomb@secutag.com
www.3SGmbH.com
Lise-Meitner-Strasse 6 D - 48301 Nottuln, Germany
 
Print this page
Send to a friend
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

4th Annual Patient Recruitment and Retention in Clinical Trials

13-15 October 2008, Amsterdam

Patient recruitment is now consuming thirty percent of clinical trial time - more time than any other clinical trial activity - and almost half of all trial delays result from patient recruitment problems. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials. With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Inefficient patient recruitment processes is a formidable barrier to pharmaceutical companies' success in launching new products. Improving the patient recruitment process is imperative to avoid wasted investments and eliminate costly delays in bringing new drugs to market -- today and even more so in the not-so-distant future. Improved patient recruitment presents one of the largest opportunities for pharmaceutical companies to eliminate delays in clinical trials, thereby making it possible to reduce time to market.  With patent time limits and large overheads meaning that any delays in the development timeline can be disastrous, a good understanding of how to successfully recruit patients for trials is vital for any company looking to succeed.
More info >>

 
News and Press Releases

Azopharma Product Development Group, Inc

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >>

 
©2000-2007 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement